EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Combined Tumor Infiltrating Lymphocytes and PD ‐ L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Catherine T Haring iD, Joshua D Smith iD, Sarah M Dermody, Jonathan B McHugh, William R Perry, Collin Brummel, Matthew E Spector iD, J Chad Brenner, Paul L Swiecicki iD

Head & Neck · 2025

DOI: 10.1002/hed.28128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Catherine T Haring und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, B7-H1 Antigen, Squamous Cell Carcinoma of Head and Neck, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine if the assessment of CD8+ tumor‐infiltrating lymphocytes (TILs) adds prognostic information to the PD‐L1 combined positive score (CPS) in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Methods

A retrospective case series was performed of 77 patients with R/M HNSCC between 2003 and 2019. From pre‐treatment biopsies, CD8+ TILs and PD‐L1 CPS were quantified on a tissue microarray. Associations of biomarkers with overall survival and immune checkpoint inhibition (ICI) response were assessed.

Results

Neither CD8+ TIL counts nor PD‐L1 CPS alone were associated with overall survival; however, combined high TILs and CPS ≥ 1 were associated with improved survival compared to low TILS and CPS < 1 (18.5 vs. 10.0 months, p = 0.058). For patients treated with ICI ( n = 28), PD‐L1 CPS predicted ICI response more strongly than CD8+ TILs.

Conclusions

In R/M HNSCC, the combination of PD‐L1 CPS and CD8+ TILs is a stronger prognostic biomarker for overall survival compared with either biomarker alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingB7-H1 AntigenSquamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalHead and Neck NeoplasmsHumansMaleRetrospective StudiesFemaleMiddle AgedAgedCD8-Positive T-LymphocytesPrognosisImmune Checkpoint InhibitorsAdultBiomarkers, TumorAged, 80 and over

Stichwörter der Autor:innen

biomarkershuman papillomavirus virusesimmune checkpoint inhibitorssquamous cell carcinoma of head and necktumor microenvironment

Substanzen

B7-H1 AntigenCD274 protein, humanImmune Checkpoint InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Catherine T Haring, Joshua D Smith, Matthew E Spector, Paul L Swiecicki

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • NIH HHS
  • University of Michigan
  • National Institutes of Health

Zitieren

APA

Haring, C. T., Smith, J. D., Dermody, S. M., McHugh, J. B., Perry, W. R., Brummel, C., Spector, M. E., Brenner, J. C., & Swiecicki, P. L. (2025). Combined Tumor Infiltrating Lymphocytes and PD ‐ L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.28128

Vancouver

Haring CT, Smith JD, Dermody SM, McHugh JB, Perry WR, Brummel C, et al. Combined Tumor Infiltrating Lymphocytes and PD ‐ L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Head & Neck. 2025. doi:10.1002/hed.28128

BibTeX
@article{Haring2025,
  author = {Haring, Catherine T and Smith, Joshua D and Dermody, Sarah M and McHugh, Jonathan B and Perry, William R and Brummel, Collin and Spector, Matthew E and Brenner, J Chad and Swiecicki, Paul L},
  title = {Combined Tumor Infiltrating Lymphocytes and PD ‐ L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28128}
}
Kostenlos starten →